Telaprevir combination therapy in treatment-naive and experienced patients co-infected with HCV and HIV

被引：0

作者：

Montes, Marisa ^{[1
]}

Nelson, Mark ^{[2
]}

Girard, Marie ^{[3
]}

Sasadeusz, Joe ^{[4
]}

Horban, Andrzej ^{[5
]}

Grinsztejn, Beatriz ^{[6
]}

Zakharova, Natalia ^{[7
]}

Falconer, Karolin ^{[8
]}

Dierynck, Inge ^{[9
]}

Luo, Donghan ^{[10
]}

Ma, Yi-Wen ^{[10
]}

Witek, James ^{[10
]}

机构：

[1] Hosp La Paz, Madrid, Spain

[2] Chelsea & Westminster Hosp, London, England

[3] Hop St Antoine, Paris, France

[4] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia

[5] Hosp Infect Dis, Warsaw, Poland

[6] Inst Pesquisa Clin Evandro Chagas, STD AIDS Clin Res Lab, Rio De Janeiro, Brazil

[7] St Petersburg AIDS Ctr, St Petersburg, Russia

[8] Karolinska Univ Hosp, Stockholm, Sweden

[9] Janssen Infect Dis BVBA, Beerse, Belgium

[10] Janssen Res & Dev LLC, Titusville, NJ USA

来源：

HEPATOLOGY | 2013年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：225A / 226A

页数：2

共 50 条

[41] Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients
Núñez, M
Soriano, V
JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 290 - 292
[42] Molecular Characterization of HBV Strains Circulating among the Treatment-Naive HIV/HBV Co-Infected Patients of Eastern India
Saha, Debraj
Pal, Ananya
Biswas, Avik
Panigrahi, Rajesh
Sarkar, Neelakshi
Das, Dipanwita
Sarkar, Jayeeta
Guha, Subhasish Kamal
Saha, Bibhuti
Chakrabarti, Sekhar
Chakravarty, Runu
PLOS ONE, 2014, 9 (02):
[43] High rates of advanced fibrosis and cirrhosis in HIV/HCV Co-infected patients naive to HCV treatment in an urban ethnically diverse cohort
Childs, K.
Bayley, J.
Byrne, R.
Suddle, A.
Agarwal, K.
Taylor, C.
HIV MEDICINE, 2012, 13 : 45 - 45
[44] The cyclophilin inhibitor DEBIO-025 has a potent dual anti-HIV and anti-HCV activity in treatment-naive HIV/HCV co-infected subjects
Flisiak, Robert
Horban, Andrzej
Kierkus, Jarek
Stanczak, Janusz
Cielnak, Iwona
Stanczak, Grzegorz P.
Wiercinska-Drapalo, Alicja
Siwak, Eva
Higersberger, Jozef
Aeschlimann, Christian
Grosgurin, Pierre
Nicolas, Valerie
Dumont, Jean-Maurice
Porchet, Herve
Crabbe, Raf
Scalfaro, Pietro
HEPATOLOGY, 2006, 44 (04) : 609A - 609A
[45] Inflammatory cells and apoptosis in HCV and co-infected HCV/HIV patients
Petrovic, L.
Rohan, S.
Hayek, E.
LIVER INTERNATIONAL, 2006, 26 : 74 - 74
[46] Comparison of therapeutic results on HCV and HCV/HIV co-infected patients
Serra, J. E.
Guzman, D.
Velez, J.
Pinto, P.
Marques, N. M.
da Cunha, J. G. Saraiva
Melico-Silvestre, A.
JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S144 - S144
[47] Provider-Based Barriers to HCV Treatment in HCV-HIV Co-Infected Patients
Surace, Lindsey T.
Wong, Michael
Baden, Rachel
GASTROENTEROLOGY, 2011, 140 (05) : S935 - S936
[48] Antiviral Treatment for Hepatitis C Virus in HIV/HCV Co-infected Patients
Ioannou, George N.
Scott, John D.
Yang, Yin
Green, Pamela
Beste, Lauren A.
HEPATOLOGY, 2013, 58 : 225A - 225A
[49] Results of a randomized controlled trial on the impact of prolonged combination anti-HCV treatment in HIV/HCV co-infected patients
Puoti, M.
Zanini, B.
De Luca, A.
Quinzan, G. P.
Allegri, R.
Bruo, R.
Orani, A.
Quirino, T.
Santantonio, T.
Pastore, G.
Cristini, G.
Suter, F.
Cauda, R.
Carosi, G.
JOURNAL OF HEPATOLOGY, 2008, 48 : S309 - S309
[50] EARLY ONSET LIVER FIBROSIS IN TREATMENT NAIVE HCV-HIV CO-INFECTED PATIENTS: A META-ANALYSIS
Janarthanan, Sailajah
Kutait, Anas
Msallaty, Zaher
Kingah, Pascal
Ditah, Ivo C.
HEPATOLOGY, 2010, 52 (04) : 680A - 681A

← 1 2 3 4 5 →